Skip to main content
Premium Trial:

Request an Annual Quote

The Time Is (Still) Right

Michael White at Adaptive Complexity promises to say something nice about systems biologists soon, but first he writes that the field is "still struggling to get beyond square 1." On his blog, he includes two passages, one from 1976 and one from 2005, that both say the time is right to take an integrated look at biology. "We're saying the same things now that we were saying 30 years ago: the time is ripe, we need a systems-level understanding, it will revolutionize biology. And yet there is still so little consensus about how to do it," White writes.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.